论文部分内容阅读
目的:对老年慢性阻塞性肺疾病的治疗进行分析。方法:从150例老年病患者中随机抽选老年慢性阻塞性肺疾病急性加重期86例患者进行检查,并分为对照组(43人)与治疗组(43人)进行分析。给予对照组止咳、氧疗、改善心肺等功能以及左氧氟沙星针0.3g与支气管的舒张剂进行常规治疗,每天2次,疗程7天。治疗组给予美洛西林舒巴坦针2.5g与支气管舒张剂进行治疗,每天2次,疗程7天。结果:经过治疗,患者的病情进一步好转,治疗组的治疗效率明显高于对照组。结论:老年慢性阻塞性肺疾病,采用药物美洛西林舒巴坦进行治疗,疗效显著,能够有效控制病情,提高生存率,应值得进一步推广。
Objective: To analyze the treatment of senile chronic obstructive pulmonary disease. Methods: A total of 86 elderly patients with chronic obstructive pulmonary disease (COPD) were randomly selected from 150 elderly patients and were divided into control group (43) and treatment group (43). Give the control group cough, oxygen therapy, improve cardiopulmonary and other functions and levofloxacin 0.3g and bronchial diastolic conventional treatment twice daily for 7 days. The treatment group was given mezlocillin sulbactam 2.5g and bronchodilator for treatment, 2 times a day for 7 days. Results: After treatment, the patient’s condition further improved, the treatment group’s treatment efficiency was significantly higher than the control group. Conclusion: Elderly patients with chronic obstructive pulmonary disease treated with mezlocillin and sulbactam have significant curative effect, which can effectively control the disease and improve the survival rate, which should be further popularized.